These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11532609)

  • 21. Invasive Haemophilus influenzae disease: changing epidemiology and host-parasite interactions in the 21st century.
    Ulanova M; Tsang RS
    Infect Genet Evol; 2009 Jul; 9(4):594-605. PubMed ID: 19460326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and structural diversity of the lipopolysaccharide of Haemophilus influenzae: implication in virulence.
    Schweda EK; Richards JC; Hood DW; Moxon ER
    Int J Med Microbiol; 2007 Sep; 297(5):297-306. PubMed ID: 17452015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of invasive Haemophilus influenzae disease in Manitoba, Canada, 2000-2006: invasive disease due to non-type b strains.
    Tsang RS; Sill ML; Skinner SJ; Law DK; Zhou J; Wylie J
    Clin Infect Dis; 2007 Jun; 44(12):1611-4. PubMed ID: 17516405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-scale approaches to identify genes essential for Haemophilus influenzae pathogenesis.
    Wong SM; Akerley BJ
    Front Cell Infect Microbiol; 2012; 2():23. PubMed ID: 22919615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial variation, virulence and vaccines.
    Moxon ER
    Microbiology (Reading); 2009 Apr; 155(Pt 4):997-1003. PubMed ID: 19332802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invasive Haemophilus influenzae disease in Manitoba in the post-vaccination era suggests a changing epidemiology.
    Can Commun Dis Rep; 2006 Jun; 32(11):125-30. PubMed ID: 16791987
    [No Abstract]   [Full Text] [Related]  

  • 27. Virulence genes and prevention of Haemophilus influenzae infections.
    Moxon ER
    Arch Dis Child; 1985 Dec; 60(12):1193-6. PubMed ID: 3879162
    [No Abstract]   [Full Text] [Related]  

  • 28. Experimental rabbit model of meningitis produced by Haemophilus influenzae serotype c.
    Sulc P; Hengstler B; Krinke G; O'Reilly T; Zak O
    J Med Microbiol; 1992 May; 36(5):312-7. PubMed ID: 1588580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease: a review for clinicians.
    Sriram KB; Cox AJ; Clancy RL; Slack MPE; Cripps AW
    Crit Rev Microbiol; 2018 Mar; 44(2):125-142. PubMed ID: 28539074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemophilus influenzae: recent advances in the understanding of molecular pathogenesis and polymicrobial infections.
    Jalalvand F; Riesbeck K
    Curr Opin Infect Dis; 2014 Jun; 27(3):268-74. PubMed ID: 24699388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Haemophilus influenzae by loop-mediated isothermal amplification (LAMP) of the outer membrane protein P6 gene.
    Torigoe H; Seki M; Yamashita Y; Sugaya A; Maeno M
    Jpn J Infect Dis; 2007 Feb; 60(1):55-8. PubMed ID: 17314429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haemophilus haemolyticus is infrequently misidentified as Haemophilus influenzae in diagnostic specimens in Australia.
    Zhang B; Kunde D; Tristram S
    Diagn Microbiol Infect Dis; 2014 Dec; 80(4):272-3. PubMed ID: 25266675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure to demonstrate special virulence of nontypable Haemophilus influenzae biotype 4 in neonatal sepsis.
    Kleiman MB; Reynolds JK; Schreiner RL; Smith JW
    J Infect Dis; 1983 Sep; 148(3):615. PubMed ID: 6604764
    [No Abstract]   [Full Text] [Related]  

  • 34. Nontypeable Haemophilus influenzae (NTHi).
    Bakaletz LO; Novotny LA
    Trends Microbiol; 2018 Aug; 26(8):727-728. PubMed ID: 29793827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial lipopolysaccharides: candidate vaccines to prevent Neisseria meningitidis and Haemophilus influenzae infections.
    Moxon ER; Hood D; Richards J
    Adv Exp Med Biol; 1998; 435():237-43. PubMed ID: 9498081
    [No Abstract]   [Full Text] [Related]  

  • 36. Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media.
    Bouchet V; Hood DW; Li J; Brisson JR; Randle GA; Martin A; Li Z; Goldstein R; Schweda EK; Pelton SI; Richards JC; Moxon ER
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8898-903. PubMed ID: 12855765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chinchilla model of experimental otitis media for study of nontypable Haemophilus influenzae vaccine efficacy.
    Green BA; Doyle WJ; Cowell JL
    Methods Enzymol; 1994; 235():59-68. PubMed ID: 8057928
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular basis of invasive Haemophilus influenzae type b disease.
    Moxon ER
    J Infect Dis; 1992 Jun; 165 Suppl 1():S77-81. PubMed ID: 1588186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genes involved in Haemophilus influenzae type b capsule expression are frequently amplified.
    Corn PG; Anders J; Takala AK; Käyhty H; Hoiseth SK
    J Infect Dis; 1993 Feb; 167(2):356-64. PubMed ID: 8421169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemophilus influenzae type b vaccination.
    Melhus A; Hemansson A
    Lancet; 1997 Jul; 350(9072):222. PubMed ID: 9250215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.